Neogen Corporation - Asset Resilience Ratio

Latest as of May 2025: 0.00%

Neogen Corporation (NEOG) has an Asset Resilience Ratio of 0.00% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Neogen Corporation for a breakdown of total debt and financial obligations.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$3.44 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1999–2025)

This chart shows how Neogen Corporation's Asset Resilience Ratio has changed over time. See Neogen Corporation book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Neogen Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Neogen Corporation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Neogen Corporation maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Neogen Corporation Industry Peers by Asset Resilience Ratio

Compare Neogen Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Revvity Inc.
NYSE:RVTY
Diagnostics & Research 0.00%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Fleury S.A.
SA:FLRY3
Diagnostics & Research 16.19%
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
Diagnostics & Research 2.10%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Bcal Diagnostics Ltd
AU:BDX
Diagnostics & Research 0.00%
Avricore Health Inc
V:AVCR
Diagnostics & Research 0.75%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%

Annual Asset Resilience Ratio for Neogen Corporation (1999–2025)

The table below shows the annual Asset Resilience Ratio data for Neogen Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-05-31 0.00% $0.00 $3.44 Billion --
2024-05-31 0.01% $325.00K $4.55 Billion -1.80pp
2023-05-31 1.81% $82.33 Million $4.55 Billion -32.09pp
2022-05-31 33.90% $336.58 Million $992.93 Million +0.70pp
2021-05-31 33.20% $305.49 Million $920.19 Million -1.60pp
2020-05-31 34.80% $277.40 Million $797.18 Million +2.34pp
2019-05-31 32.46% $225.84 Million $695.74 Million +11.79pp
2018-05-31 20.67% $127.74 Million $618.01 Million +8.17pp
2017-05-31 12.50% $66.07 Million $528.41 Million +0.87pp
2016-05-31 11.63% $52.54 Million $451.71 Million -0.63pp
2015-05-31 12.27% $48.10 Million $392.18 Million +1.89pp
2014-05-31 10.37% $35.82 Million $345.30 Million -1.84pp
2013-05-31 12.22% $35.34 Million $289.25 Million +4.43pp
2012-05-31 7.79% $19.60 Million $251.60 Million -1.42pp
2011-05-31 9.21% $20.24 Million $219.66 Million +9.04pp
2006-05-31 0.17% $150.00K $88.29 Million -0.38pp
2004-05-31 0.55% $331.00K $59.98 Million -15.76pp
2003-05-31 16.31% $7.84 Million $48.04 Million +5.43pp
2002-05-31 10.88% $4.34 Million $39.90 Million -8.30pp
2001-05-31 19.18% $6.33 Million $33.02 Million -9.51pp
2000-05-31 28.69% $8.47 Million $29.53 Million -8.09pp
1999-05-31 36.78% $9.60 Million $26.10 Million --
pp = percentage points

About Neogen Corporation

NASDAQ:NEOG USA Diagnostics & Research
Market Cap
$2.07 Billion
Market Cap Rank
#6121 Global
#1850 in USA
Share Price
$9.53
Change (1 day)
+1.38%
52-Week Range
$4.65 - $11.33
All Time High
$48.34
About

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne path… Read more